ARCHIVES

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

Division Directors Won’t Control Grants Budget, Upton Insists

February 24, 1978

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994